Thus, the therapeutic targeting of EV trafficking may help to prevent cancer progression—and even potentiate the use of other anticancer therapies—by simultaneously reducing TGF‐β signalling levels across multiple tumour compartments. This evidence concerns the gene TGFB1 and neoplasm.